We are live on ! Find out more
ZSAN

Zosano Pharma Corporation

Delisted

ZSAN was delisted on the 10th of June, 2022.

31 hedge funds and large institutions have $5.92M invested in Zosano Pharma Corporation in 2020 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

14% more capital invested

Capital invested by funds: $5.22M → $5.92M (+$705K)

7% more funds holding

Funds holding: 2931 (+2)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
31
Holders Change
+2
Holders Change %
+6.9%
% of All Funds
0.64%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
8
Increased
6
Reduced
4
Closed
6
Calls
Puts
Net Calls
Net Calls Change

ZSAN Hedge Fund Activity: Q2 2020 in Review

31 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q2 2020, worth a combined $5.92M — up 14% from $5.22M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new ZSAN positions and 6 closed out — a net gain of 2 holders — while 6 added to existing stakes and 4 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $191K. The largest seller was Telemetry Investments, cutting an estimated $2.05M.

  • 31 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q2 2020, up from 29 in Q1 2020.
  • Funds reported $5.92M of Zosano Pharma Corporation stock for Q2 2020, up 14% quarter-over-quarter.
  • 8 funds opened new Zosano Pharma Corporation positions in Q2 2020 and 6 closed out, a net change of +2 holders.
  • The largest Zosano Pharma Corporation buyer in Q2 2020 was Geode Capital Management, an estimated $191K added.
  • The largest Zosano Pharma Corporation seller in Q2 2020 was Telemetry Investments, an estimated $2.05M sold.

Based on aggregated 13F filings for Q2 2020.